FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA to Cut Another 3,500 Employees Under HHS Plan

[ Price : $8.95]

HHS says FDA will lose about 3,500 (18%) of its 19,000 full-time employees under a just-announced reductions in force plan to cons...

FDA Likely to Miss Review Deadlines: Staff

[ Price : $8.95]

An exclusive Reuters report says FDA is likely to miss medical device user fee deadlines due to staff shortages from two rounds of...

Solenos Vykat OKd for Prader-Willi Hyperphagia

[ Price : $8.95]

FDA approves a Soleno Therapeutics NDA for Vykat XR (diazoxide choline) extended-release tablets for treating hyperphagia in indiv...

Prometheus, Owner Paying $550,000 for False Claims

[ Price : $8.95]

The Department of Justice reaches a settlement in which medical device company Prometheus and its owner agree to pay $550,000 to r...

Merck Seeks Approval for Subcutaneous Keytruda

[ Price : $8.95]

FDA accepts a Merck BLA for a subcutaneous formulation of Keytruda (pembrolizumab) for its use across all previously approved soli...

Fresenius Prolia, Xgeva Biosimilars Approved

[ Price : $8.95]

FDA approves Fresenius Kabi BLAs for biosimilar denosumab products that reference Amgens Prolia and Xgeva.

FDA Clears Vasorum Vascular Closure Device

[ Price : $8.95]

FDA clears a Vasorum 510(k) for the Celt ACD Plus vascular closure device.

Makary Wins Senate Floor Vote on FDA Confirmation

[ Price : $8.95]

A Senate floor vote moves Marty Makary one step closer to becoming the next FDA commissioner.

CGMP Violations at Chinas Yangzhou Sion

[ Price : $8.95]

FDA warns Chinas Yangzhou Sion Commodity Co. about CGMP violations in its manufacturing of finished drugs.

AstraZeneca Touts New Tagrisso Data

[ Price : $8.95]

AstraZeneca says new study data on Tagrisso (osimertinib) show an improved overall survival trend in certain patients with non-sma...